Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

12-Oct-18 - 10-Oct-19
Buy Ratio:36%

Up

# Net Buyers:100
# Net Sellers:179

Previous 52 Weeks

13-Oct-17 - 11-Oct-18
Buy Ratio:33%
# Net Buyers:102
# Net Sellers:206
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Juno Therapeutics, Inc.--$1.28B  
Corium International, Inc.$299.40M$301.61M  
Sucampo Pharmaceuticals, Inc.--$197.12M  
Usana Health Sciences Inc($18.56M)$191.87M  
Regeneron Pharmaceuticals, Inc.($245.31M)$188.71M  
New Net Buyers
CompanyNet Buy AmountChange
Corium International, Inc.$299.40M$301.61M  
Heron Therapeutics, Inc. /de/$5.13M$114.90M  
Amyris, Inc.$23.51M$78.89M  
Medicines Co /de$59.67M$60.61M  
Myriad Genetics Inc$4.72M$42.05M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.($3.37B)($3.39B)  
Osiris Therapeutics, Inc.($281.65M)($281.65M)  
Seattle Genetics Inc /wa($20.28M)($267.64M)  
Spark Therapeutics, Inc.($256.00M)($248.43M)  
Mirati Therapeutics, Inc.($234.40M)($223.89M)  
New Net Sellers
CompanyNet Buy AmountChange
Tesaro, Inc.($3.37B)($3.39B)  
Seattle Genetics Inc /wa($20.28M)($267.64M)  
Intercept Pharmaceuticals, Inc.($82.23M)($94.76M)  
Kalvista Pharmaceuticals, Inc.($37.47M)($56.43M)  
Immune Design Corp.($42.92M)($54.56M)